Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
The Annals of Pharmacotherapy|February 8, 2007
Effects of St. John's wort supplementation on ibuprofen pharmacokineticsEdward C Bell, William R Ravis, Kimberly Braxton Lloyd, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2005
Doxycycline may reduce the incidence of aneurysms in haemodialysis vascular accessesCharles Diskin, Thomas J Stokes, Linda M Dansby, et al.Journal of Nephrology|March 30, 2010
Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders?Charles J Diskin, Thomas J Stokes, Linda M Dansby, et al.Nephron. Clinical Practice|October 25, 2007
Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factorsCharles J Diskin, Thomas J Stokes, Linda M Dansby, et al.Nature Clinical Practice. Nephrology|September 25, 2008
Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapiesCharles J Diskin, Thomas J Stokes, Linda M Dansby, et al.Seminars in Dialysis|June 25, 2008
Beyond anemia: the clinical impact of the physiologic effects of erythropoietinCharles J Diskin, Thomas J Stokes, Linda M Dansby, et al.Kidney & Blood Pressure Research|April 29, 2006
Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition?Charles J Diskin, Thomas J Stokes, Linda M Dansby, et al.Renal Failure|October 20, 2010
Toward the optimal clinical use of the fraction excretion of solutes in oliguric azotemiaCharles J Diskin, Thomas J Stokes, Linda M Dansby, et al.The American Journal of the Medical Sciences|September 14, 2006
Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal diseaseCharles J Diskin, Thomas J Stokes, Linda M Dansby, et al.Clinical Lung Cancer|August 8, 2007
Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitoninCharles J Diskin, Thomas J Stokes, Linda M Dansby, et al.Pageof 3